AI assistant
InspireMD, Inc. — Director's Dealing 2020
Sep 2, 2020
34187_dirs_2020-09-02_e33037ef-c4d3-4430-927f-e30f2858d625.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2020-08-31
Reporting Person: Kester Thomas J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-08-31 | Common Stock | A | 158033 | — | Acquired | 210633 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-08-31 | Options to purchase common stock (right to buy) | $0.39 | A | 52678 | Acquired | 2030-08-31 | Common Stock (52678) | Direct |
Footnotes
F1: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service.
F2: Consists of (i) an aggregate of 160,633 shares of common stock represented by restricted stock, which have vested or vest over time, subject to the Reporting Person's continued service, and (ii) 50,000 shares of common stock.
F3: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service.